Menu
Recruiting NCT06384079

Duration of Ureteral Rest Prior to Ureteral Reconstruction Surgery

Observational Ureteral Stricture

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Antegrade and retrograde pyelogram.
Who it may be relevant to
Registry conditions: Ureteral Stricture. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Study to Assess Duration of Ureteral Rest Prior to Ureteral Reconstruction Surgery

Overview

Our objective is to assess the effect of duration of ureteral rest, defined as time from conversion of ureteral stent to percutaneous nephrostomy, on stricture length prior to ureteral reconstruction surgery.

Interventions

  • Procedure Antegrade and retrograde pyelogram
    Participation in the study will guarantee that participants will receive this procedure.

Primary outcome measures

  • Ureteral stricture length measured by antegrade or retrograde pyelogram [Time frame: 2 weeks and 6 weeks post procedure]
Secondary outcome measures (1)
  • Ureteral Stricture Quality will be graded as either narrowed or obliterated segment. [Time frame: 2 weeks and 6 weeks post procedure]

Eligibility criteria

Inclusion criteria

  • >18 years of age
  • Undergoing ureteral reconstruction surgery for ureteral stricture with conversion of an indwelling stent to a percutaneous nephrostomy tube for ureteral rest
  • Willing to sign informed consent form
  • Able to read and understand informed consent form

Exclusion criteria

  • <18 years of age
  • Inability to provide informed consent
  • Members of vulnerable patient populations

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Northwestern University — Chicago

Identifiers

NCT: NCT06384079 · STU00219828

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗